Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.8.0.1
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Revenues:    
Revenues and management fees from company clinics $ 11,125,115 $ 8,550,980
Royalty fees 7,722,856 5,973,079
Franchise fees 1,442,415 2,286,809
Advertising fund revenue 2,753,776 1,866,406
IT related income and software fees 1,137,363 932,709
Regional developer fees 583,550 617,573
Other revenues 398,929 296,084
Total revenues 25,164,004 20,523,640
Cost of revenues:    
Franchise cost of revenues 2,996,797 2,717,691
IT cost of revenues 315,397 221,918
Total cost of revenues 3,312,194 2,939,609
Selling and marketing expenses 4,473,881 4,419,180
Depreciation and amortization 2,017,323 2,566,136
General and administrative expenses 18,117,533 22,086,321
Total selling, general and administrative expenses 24,608,737 29,071,637
Loss on disposition or impairment 417,971 3,520,370
Loss from operations (3,174,898) (15,007,976)
Other expense, net (64,455) (1,467)
Loss before income tax expense (3,239,353) (15,009,443)
Income tax expense (35,880) (164,429)
Net loss and comprehensive loss $ (3,275,233) $ (15,173,872)
Loss per share:    
Basic and diluted loss per share (in dollars per share) $ (0.25) $ (1.20)
Basic and diluted weighted average shares outstanding (in shares) 13,245,119 12,696,649